American Society of Clinical Oncology (ASCO)

What it reported doing in 2024

Policy: in collaboration with volunteer experts, asco works to address a wide range of policy issues that impact the cancer care delivery system and people with cancer. Policy is conveyed in formal statements published in asco journals, and in public facing communications channels. Areas of focus include quality and access to care, insurance issues, cost, prevention, survivorship, reimbursement, and support for clinical cancer research. In 2024, asco continued to draw public attention to the persistent crisis of drug shortages, the ongoing and worsening harms related to aggressive utilization management practices, the need to sustain access to evidence based cancer care, the need to balance benefits/harms associated with use of artificial intelligence in cancer care, and the importance of telemedicine as a component of health care delivery.center for global impact (cgi): asco's international affairs department has transitioned to the center for global impact (cgi). Cgi partners across asco and oncology communities worldwide to integrate global perspectives into asco strategies and operations, and to catalyze and advance asco's global impact goals as directed by the society's mission, vision, and strategic plans. Cgi serves as a resource across asco for global issues relevant to asco, with a particular emphasis on volunteer engagement, diplomacy, strategic planning, program delivery, and global operations. Examples of operations are as follows:- joint sessions- international cancer corps- international courses- international development and education award (idea)scientific publications: asco produces a number of professional publications and general publications focused on clinical oncology. Asco publishes high-quality, peer-reviewed scientific papers in its journals: - journal of clinical oncology (jco)- jco oncology practice (jco op)- jco global oncology (jco go)- jco clinical cancer informatics (jco cci)- jco precision oncology (jco po)- jco oncology advances (jco oa)- asco daily newsasco also provides content and distribution lists for trade publications. While not owned or published by asco, the publications cover news and information of interest to the professional oncology community.education and professional development: in 2024, asco launched the inaugural leadership development program (ldp): latin america class of 12, creating a network of physician leaders to advance cancer care. In 2024, asco had record virtual mentoring program participation (68% increase), resulting in the creation of a technological solution to meet the demand. The in-training exam for oncology fellows had record participation with 2333 trainees from 20 countries across the globe participating. All programs serve the purpose of building the workforce.

Financial Efficiency

• Mission deployment rate: 67.1%; rating input score 67
• Program expense ratio: 76.3%; rating input score 76
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 92.9%; rating input score 93; 17th percentile among comparable filings
• Pay-setting controls: 5 of 6 controls in place; rating input score 83
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Pass
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: 1 of 8 controls in place; rating input score 12
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Limited
  • Conducts field audits: Limited
  • May suspend future funding: Limited
  • Requires financial reports: Limited
  • Conducts site visits: Limited
  • Requires grant agreements: Limited
  • May require repayment: Limited
• Grant itemization coverage: 94.8%; rating input score 95; 27th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 100%; rating input score 100; 77th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 9.7%; rating input score 72; 72nd percentile among comparable filings
• Total-asset coverage ratio: 2.24; rating input score 67; 67th percentile among comparable filings
• Liabilities to assets ratio: 0.35; rating input score 51; 51st percentile among comparable filings
• Officer compensation ratio: 5.8%; rating input score 12; 12th percentile among comparable filings

Growth

• Program expense growth: 4.1% per year; rating input score 100; 32nd percentile among comparable filings
• Revenue growth: 5.4% per year; rating input score 100; 47th percentile among comparable filings
• Asset growth: 4.6% per year; rating input score 100; 33rd percentile among comparable filings